ADPT — Adaptive Biotechnologies Share News
0.000.00%
Last trade - 00:00- $3.35bn
- $3.27bn
- $276.98m
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile
Adaptive Biotechnologies up after boosted $300 mln convertible bond sale
Brief: Adaptive Biotechnologies Announces Proposed Convertible Senior Notes Offering
Adaptive Biotechnologies plans separation of immune medicine platform
Adaptive Biotechnologies falls after announcing convertible, separation of businesses
Brief: Adaptive Biotechnologies announces plan to separate its MRD and Immune Medicine Businesses
Adaptive Biotechnologies Q1 revenue beats estimates on MRD growth
Brief: Adaptive Biotechnologies Q1 EPS USD -0.13
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
Adaptive Biotechnologies Q4 revenue beats estimates
Brief: Adaptive Biotechnologies Q4 EPS USD -0.09
Brief: Adaptive Biotechnologies Announces Preliminary Fourth Quarter And Full Year 2025 Results
Brief: Adaptive Biotechnologies Corp - Unit Held Initial Closing $15 Million Series A Financing - SEC Filing
Brief: Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals With Pfizer
Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research (updated)
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million